| 股號 / 名稱 | 總負債 | 淨值 |
| ABT 美國雅培 | 1,085,760,788,859.9 | 1,636,662,808,989.0 |
| MDT 美敦力 | 1,334,321,300,250.0 | 1,537,923,032,770.5 |
| NVO 諾和諾德 | 1,722,840,860,643.71 | 958,312,480,788.09 |
| BSX Boston Scientific Corp | 610,334,260,632.0 | 760,814,307,504.9 |
| SYK 史賽克 | 798,206,699,707.2 | 703,893,730,626.0 |
| PHG Koninklijke Philips NV | 589,518,714,602.01 | 404,100,217,353.24 |
| ZBH Zimmer Biomet Holdings Inc | 326,327,896,348.2 | 398,654,389,980.81 |
| BIO Bio Rad Laboratories Inc | 98,045,929,142.37 | 234,011,699,848.08 |
| RMD 瑞思邁 | 68,521,040,680.09 | 198,449,023,200.07 |
| NVST Envista Holdings Corp | 80,771,962,568.31 | 97,524,758,940.39 |
| ICUI ICU Medical Inc | 60,489,745,075.99 | 66,679,174,953.02 |
| NEOG Neogen Corp | 39,416,322,146.31 | 66,072,074,459.31 |
| QDEL QuidelOrtho Corp | 120,836,136,950.64 | 60,295,624,873.65 |
| EYE National Vision Holdings Inc | 34,526,301,445.16 | 26,961,484,567.62 |
| INMD Inmode Ltd | 2,613,103,438.61 | 21,449,544,557.37 |
| TGTX TG Therapeutics Inc | 13,117,351,651.11 | 19,064,092,030.48 |
| ATRC AtriCure Inc | 5,093,779,412.65 | 15,444,690,560.91 |
| WRBY Warby Parker Inc | 11,088,649,546.21 | 11,545,175,805.67 |
| BLFS BioLife Solutions Inc | 1,203,777,583.39 | 11,105,917,233.63 |
| PAHC Phibro Animal Health Corp | 33,693,716,349.6 | 10,434,737,921.7 |
| QTRX Quanterix Corp | 4,069,083,445.65 | 9,875,045,078.89 |
| ORMP Oramed Pharmaceuticals Inc | 540,353,032.91 | 6,382,200,060.17 |
| VALN Valneva SE | 10,970,814,601.15 | 5,544,396,909.97 |
| VMD Viemed Healthcare Inc | 2,158,523,718.47 | 4,194,729,418.44 |
| UTMD Utah Medical Products Inc | 116,886,545.9 | 3,712,615,585.82 |
| CAPR Capricor Therapeutics Inc | 1,336,548,831.93 | 2,633,079,327.33 |
| MGNX MacroGenics Inc | 6,397,270,041.92 | 2,103,549,680.9 |
| CERS Cerus Corp | 4,826,224,445.11 | 1,929,679,766.52 |
| INFU InfuSystem Holdings Inc | 1,357,365,814.0 | 1,799,795,361.37 |
| ZVIA Zevia PBC | 274,995,771.03 | 1,609,034,509.13 |
| VERU Veru Inc | 327,865,976.36 | 1,165,538,760.55 |
| RMTI Rockwell Medical Inc | 642,546,346.61 | 1,162,272,342.01 |
| ICCC ImmuCell Corp | 500,112,414.16 | 935,621,072.41 |
| XGN Exagen Inc | 1,402,921,112.98 | 569,456,935.15 |
| MYO Myomo Inc | 610,706,300.81 | 459,181,715.82 |
| SNES Senestech Inc | 102,852,625.4 | 356,279,485.06 |
| UG United-Guardian Inc | 50,167,655.27 | 332,244,120.01 |
| NEPH Nephros Inc | 101,753,772.57 | 314,146,327.77 |
| CLRB Cellectar Biosciences Inc | 164,773,296.64 | 294,471,524.73 |
| CTSO Cytosorbents Corp | 1,153,167,561.37 | 283,190,073.61 |
| APYX Apyx Medical Inc | 1,617,417,186.47 | 183,602,610.91 |
| IMCC IM Cannabis Corp | 910,829,126.77 | 89,415,537.4 |
| GCTK GlucoTrack Inc | 173,901,310.17 | 86,369,832.87 |
| PHGE Biomx Inc | 222,439,209.7 | -40,877,325.48 |
| EOLS Evolus Inc | 7,778,528,056.14 | -902,943,072.83 |
| OMER Omeros Corp | 12,752,469,718.14 | -6,922,082,156.15 |
| BRBR Bellring Brands Inc | 49,322,794,416.3 | -16,033,832,659.71 |
載入數據中...
最新要聞
和醫療產品相關的產業概念股
醫療產品概念股相關指標排名
醫療產品每月營收
醫療產品每股盈餘
醫療產品每股淨值
醫療產品損益表
醫療產品總資產
醫療產品負債和股東權益
醫療產品現金流量表
醫療產品利潤比率
醫療產品營業費用率拆解
醫療產品杜邦分析
醫療產品ROE / ROA
醫療產品經營週轉能力
醫療產品營運週轉天數
醫療產品現金股利發放率
醫療產品財務結構比率
醫療產品流速動比率
醫療產品利息保障倍數
醫療產品現金流量分析
醫療產品營業現金流對淨利比
醫療產品盈餘再投資比率
醫療產品月營收成長率
醫療產品營收成長率
醫療產品毛利成長率
醫療產品營業利益成長率
醫療產品稅後淨利成長率
醫療產品每股盈餘成長率
醫療產品本益比評價
醫療產品股價淨值比評價
醫療產品現金股利殖利率
醫療產品平均現金股息殖利率
醫療產品董監持股比例
醫療產品董監持股質押比例